Key Highlights

  • Kyndryl (NYSE:KD) traded at USD 16.50 intraday on November 4, 2026, up 27.47%, after it released fiscal 2027 second quarter results before the open.
  • Signings reached USD 4.1 billion against USD 2.8 billion a year earlier, while adjusted EBITDA rose to USD 699 million, a 19.1% margin.
  • Revenue of USD 3.7 billion fell 1.9% as reported, and free Cash Flow was negative USD 34 million, so the quarter was mixed beneath the headline gain.
  • Management reaffirmed fiscal 2027 guidance for adjusted pretax income of USD 600 million to USD 700 million and free cash flow of USD 400 million to USD 500 million.

What Moved Kyndryl During Trading (up USD 3.56, 27.47%)

Kyndryl (NYSE:KD) was quoted at USD 16.50 intraday on November 4, 2026, up 27.47% on published market data, which implies a prior close of about USD 12.94 (calculated). The company reported fiscal second quarter results for the period ended September 30, 2026, with a call at 8:30 a.m. ET. Revenue was USD 3,651 million, down 1.9% as reported and down 0.8% in constant currency. Net Income was USD 59 million, or USD 0.27 per diluted share, and adjusted net income was USD 92 million, or USD 0.42 per share, against USD 0.38 a year earlier. Intraday Volume was about 3.31 million shares at a Market Value near USD 3.59 billion.

Signings, Margins and Reaffirmed Guidance

The main driver appears to be Demand and profitability rather than sales growth. Second quarter signings of USD 4.1 billion compared with USD 2.8 billion a year earlier, and six month signings reached USD 8.0 billion against USD 6.0 billion. Adjusted EBITDA rose to USD 699 million from USD 641 million as the Margin widened to 19.1% from 17.2%. Management reaffirmed fiscal 2027 adjusted pretax income of USD 600 million to USD 700 million, free cash flow of USD 400 million to USD 500 million and constant currency revenue of flat to down 2%. Workforce Rebalancing charges are expected near USD 200 million, with USD 190 million incurred in the first half, and annualized savings of USD 400 million to USD 500 million are targeted for fiscal 2028.

Cash Flow, Debt and What Could Reverse the Move

Free cash flow was negative USD 34 million in the quarter and negative USD 434 million for six months, so the full-year range depends on a strong second half. Signings are contract value, not recognized revenue, and convert to sales over several years. The company issued USD 600 million of senior notes due 2029 and USD 400 million due 2032 on September 28, 2026, and repaid USD 700 million of 2.05% notes in October 2026. A gain of this size in one session can partly reverse if the second half cash flow falls short, and the published price to Earnings ratio of about 45.99 reflects depressed trailing earnings.

Where Things Stand

Kyndryl (NYSE:KD) is up 27.47% intraday because the fiscal second quarter release showed stronger demand in signings, a wider adjusted EBITDA margin and an unchanged full-year outlook. The reported revenue decline and Negative cash flow were outweighed by that signal. The next test is whether second half free cash flow reaches the USD 400 million to USD 500 million range and whether signings turn into revenue growth. The fiscal third quarter report will show the progress.